NOTICE OF BREACH AND TERMINATIONClinical Development and License Agreement • August 31st, 2006 • Biodelivery Sciences International Inc • Pharmaceutical preparations
We make reference to the Clinical Development and License Agreement dated as of July 14, 2005 among BioDelivery Sciences International, Inc, (“BDSI”), Clinical Development Capital LLC (together with its successors and assigns, “CDC”), and Arius Pharmaceuticals, Inc. (such agreement, as amended, the “CDLA”).
